Genomics
10
1
2
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 10 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
33%
1 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (10)
Integrating Tumor Genomics and Urinary Exosomal Proteomics to Establish a Multi-Layer Biomarker Framework for Early Risk Stratification and Post-Treatment Surveillance in Fresh Thyroid Cancer Patients
Insights Into Microbiome and Environmental Contributions to Sickle Cell Disease and Leg Ulcers Study (INSIGHTS Study)
GenoDrugP 2025: Study on Three-dimensional Models Derived From Brain Tumors in Pediatric Patients
Metabolism Imaging-genomics for Predicting the Surgical Outcomes of Colorectal Cancer
Genetic Testing to Understand and Address Renal Disease Disparities
Molecular Imaging Visualization of Tumor Heterogeneity in Non-small Cell Lung Cancer
Postprandial Effects of Milk Fats
Multi-omics Study on the Pathogenesis of Malignant Transformation of Adenomyosis
A Multi-omics Study of Adenomyosis
Clinical Integration of Genetic Risk Assessment in Family Medicine